An active new formulation of iron carried by aspartyl casein for iron-deficiency anemia: results of the ACCESS trial

Oral iron supplementation is the cornerstone for the management of iron-deficiency anemia. A new oral formulation of iron conjugated with N-aspartyl-casein (Fe-ASP) (Omalin®, Uni-Pharma) is studied in the ACCESS double-blind, double-dummy randomized clinical trial; 60 patients were randomized to 12-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsilika, Maria, Mitrou, John, Antonakos, Nikolaos, Tseti, Ioulia K., Damoraki, Georgia, Leventogiannis, Konstantinos, Giamarellos-Bourboulis, Evangelos J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182142/
https://www.ncbi.nlm.nih.gov/pubmed/37022473
http://dx.doi.org/10.1007/s00277-023-05197-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182142/
https://www.ncbi.nlm.nih.gov/pubmed/37022473
http://dx.doi.org/10.1007/s00277-023-05197-3

Ejemplares similares